Price Alert

Gelteq Limited Ordinary S... (GELS)

NASDAQ: GELS · Real-Time Price · USD

1.17

0.04 (3.55%)

At close: Sep 03, 2025, 3:57 PM

3.55% (1D)

Bid	1.15
Market Cap	11.73M
Revenue (ttm)	-1
Net Income (ttm)	-2.08M
EPS (ttm)	-0.35
PE Ratio (ttm)	-3.34
Forward PE	n/a
Analyst	n/a

Ask	1.18
Volume	483,563
Avg. Volume (20D)	1,393,156
Open	1.15
Previous Close	1.13
Day's Range	1.15 - 1.17
52-Week Range	0.77 - 5.50
Beta	-4.93

About GELS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol GELS

Website n/a

Full Company Profile

Why Price Moved

2 months ago

+73.53%

Gelteq shares are trading higher after the company... Unlock content with Pro Subscription

9 months ago

+91.02%

Gelteq shares are trading higher after the company announced Healthy Extracts, its largest customer, increased its initial purchase order of Gelteq collagen and Mynus sugar blocker gels by 50%.

News

Just now · accessnewswire.com

Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs

Hydrate EZ™ delivers rapid hydration and essential electrolytes for staying refreshed, sharp and in control. Mynus Sugar™ is clinically formulated to support healthy carbohydrate metabolism.

3 weeks ago · accessnewswire.com

Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%

Net Revenue Outlook for 2025 Increased from $4.2 Million+ to $6.3 Million+, Representing Growth of 102%+, Based on Recent Transformative Merger with Gummy USA LAS VEGAS, NV / ACCESS Newswire / August ...

1 month ago · accessnewswire.com

Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA

Q2 2025 adjusted EBIDTA at nearly $100,000, demonstrating strong leverage in the company's marketing and distribution channel platform. Subscription-based recurring revenue continues to drive strong p...